AHGIF (Alternate Health) ROE % Adjusted to Book Value: 0.00% (As of Sep. 2019)


What is Alternate Health ROE % Adjusted to Book Value?

Alternate Health AHGIF -99.00% ROE % Adjusted to Book Value is 0.00% as of Sep. 2019.

Alternate Health's ROE % for the quarter that ended in Sep. 2019 was 0.00%. Alternate Health's PB Ratio for the quarter that ended in Sep. 2019 was N/A. Alternate Health's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2019 was N/A.

Alternate Health ROE % Adjusted to Book Value Related Terms

Alternate Health ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Alternate Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alternate Health ROE % Adjusted to Book Value Chart

Alternate Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18
ROE % Adjusted to Book Value
0.00 0.00 0.00 -45.28 -9.53

Alternate Health Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -42.62 -50.32 0.00 0.00 0.00

AHGIF vs VEEV, CERN, TDOC: ROE % Adjusted to Book Value Comparison

For the Health Information Services subindustry, Alternate Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alternate Health ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alternate Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alternate Health's ROE % Adjusted to Book Value falls into.


Alternate Health ROE % Adjusted to Book Value Calculation

Alternate Health's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2018 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-266.22% / 27.93
=-9.53%

Alternate Health's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2019 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Alternate Health (AHGIF) has a ROE % Adjusted to Book Value of 0.00% as of Sep. 2019. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Alternate Health and its competitors.
Is Alternate Health's ROE % Adjusted to Book Value too high?
Alternate Health's current ROE % Adjusted to Book Value is 0.00%.
How does Alternate Health's ROE % Adjusted to Book Value compare to VEEV and CERN?
Alternate Health's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Alternate Health and its competitors. Alternate Health's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alternate Health stock overvalued right now?
Alternate Health (AHGIF) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Alternate Health (AHGIF), the current ROE % Adjusted to Book Value is 0.00% as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alternate Health Business Description

Address 7373 Broadway Street, Suite 307, San Antonio, TX, USA, 78209
Alternate Health Corp is a healthcare company. It uses expertise in technology and data analytics to revolutionize patient care and research in the emerging medical cannabis industry. It offers practice management and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry.